Back to Top
Human IgG1 Kappa Isotype Control LALAPG - MMAE(PEG8) DAR4
$1,220.00 - $4,355.00
Human IgG1 Kappa Isotype Control LALAPG - MMAE(PEG8) DAR4
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Species Reactivity
Human
Target
Hen Egg Lysozyme
Isotype
Human IgG1
Buffer
ICH3001
Shipping Conditions
Blue ice
Background
Effector-silenced ADC formats require non-targeting controls that share the same Fc engineering. Bearing LALA-PG mutations, this human IgG1 kappa isotype control is directed against hen egg lysozyme, a non-mammalian antigen, and therefore provides no specific binding while acting as a matched negative reference. It is conjugated with MMAE via a PEG8 linker at a drug-to-antibody ratio of 4 (DAR4), allowing researchers to benchmark payload and Fc-silenced framework effects independent of antigen binding when setting background and gating. The reagent is research use only, supplied in a low-endotoxin format suitable for in vivo use and produced in scalable milligram (mg) to gram (g) quantities for bulk research.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives. 0.2 μM filtered
Storage
The product should be stored in the original stock concentration at 4°C. Avoid freeze / thaw cycles.
Use
Research Use Only. Not for Therapeutic or Diagnostic Use
Write Your Own Review












